Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2 –positive early breast cancer: analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials

Cancer, EarlyView.

Source: Cancer - October 18, 2018 Category: Cancer & Oncology Authors: Matteo Lambertini, Samuel Martel, Christine Campbell, S ébastien Guillaume, Florentine S. Hilbers, Uwe Schuehly, Larissa Korde, Hatem A. Azim, Serena Di Cosimo, Richard C. Tenglin, Jens Huober, José Baselga, Alvaro Moreno‐Aspitia, Martine Source Type: research